文献速递其他结缔组织病

抗MDA5皮肌炎快速进展性间质性肺病的预测因素:一项Meta分析

Predictors of rapidly progressive interstitial lung disease in anti-MDA5 dermatomyositis: a meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

OBJECTIVES: Anti-MDA5 antibody-positive DM (MDA5+DM) is frequently complicated by rapidly progressive interstitial lung disease (RP-ILD).…

要点

  • 高龄、男性、发热、皮肤溃疡和关节炎是MDA5+DM患者发生RP-ILD的临床预测因素。
  • CRP、LDH、AST、铁蛋白、ESR、白细胞、KL-6、ALT、抗Ro52抗体阳性及高滴度抗MDA5抗体与RP-ILD风险升高相关。
  • 淋巴细胞、白蛋白、PaO2/FiO2比值及CD3+CD4+ T细胞计数降低与RP-ILD相关。

核心结论

  • 该Meta分析识别出多个临床和实验室参数可作为MDA5+DM患者RP-ILD进展的显著预测因素。

研究设计与样本

  • 由两名评价者提取数据并评估偏倚风险,系统总结人群特征、临床特征和实验室指标。
  • 主要效应量以标准化均数差(SMD)、比值比(OR)及相应95%CI呈现。

主要发现

  • RP-ILD组高龄、男性、发热、皮肤溃疡和关节炎的占比或水平显著更高。
  • RP-ILD组CRP、LDH、AST、铁蛋白、ESR、白细胞、KL-6、ALT、软骨糖蛋白39、抗Ro52抗体阳性及高滴度抗MDA5抗体水平显著升高。
  • RP-ILD组淋巴细胞、白蛋白、PaO2/FiO2比值及CD3+CD4+ T细胞计数显著降低。

临床怎么用

  • 对MDA5+DM患者可结合上述临床特征和实验室指标早期识别RP-ILD高风险人群,以便及时干预。

局限性

  • 需要高质量的前瞻性研究验证这些关联,并识别更多用于早期预测RP-ILD发生的生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Anti-MDA5 antibody-positive DM (MDA5+DM) is frequently complicated by rapidly progressive interstitial lung disease (RP-ILD). The current study aims to identify predictors for the development of RP-ILD in MDA5+DM, thereby providing an objective basis for early intervention strategies. METHODS: We searched the PubMed, Embase, Web of Science and Cochrane Library databases and extracted studies published before December 2024. Two reviewers extracted data and assessed risk of bias. Population characteristics, clinical features and laboratory indicators were systematically summarized. For the overall main effects, results were presented as standardized mean differences (SMDs), odds ratios (ORs) and corresponding 95% CIs. RESULTS: Twenty-seven cohorts with 2579 patients were included in this meta-analysis. The results demonstrated that clinical characteristics predictive of RP-ILD risk factors included advanced age, male sex, fever, skin ulcers and arthritis. Specifically, the RP-ILD group exhibited significantly elevated levels of laboratory parameters including CRP, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), ferritin, ESR, leukocytes, Krebs von den Lungen-6 (KL-6), alanine aminotransferase (ALT), cartilage glycoprotein 39, positive anti-Ro52 antibodies and high-titre anti-MDA5 antibodies. Conversely, the RP-ILD group demonstrated significantly reduced levels of lymphocytes, albumin, PaO2/FiO2 ratio and CD3+CD4+ T cell count. CONCLUSION: This meta-analysis identified multiple clinical and laboratory parameters as significant predictors of RP-ILD progression in MDA5+DM patients. High-quality prospective studies are essential to validate these associations and identify additional biomarkers for the early prediction of RP-ILD onset in MDA5+DM patients, which will facilitate timely therapeutic interventions aimed at reducing mortality.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Liu T, Ji X, Wei Y, et al. Predictors of rapidly progressive interstitial lung disease in anti-MDA5 dermatomyositis: a meta-analysis. Rheumatology (Oxford). 2026. PMID: 42334960. doi:10.1093/rheumatology/keag311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。